Inter-American Mental Health Week calls for intersectoral action to improve mental health in the Americas - Pan American Health Organization (PAHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
More than 185 million people live with mental health conditions in the Americas. Addressing the challenge requires action beyond the health sector. Washington, D. C., 6 October 2026 (PAHO) – The Pan American Health Organization (PAHO) and the Organization of American States (OAS) are marking Inter-American Mental Health Week 2026 (October 5–9) with a call to strengthen intersectoral action to improve mental health and well-being across the Americas, where more than 185 million people live with a mental health condition. Under the theme “From commitment to action: Advancing mental health through intersectoral action in the Americas,” the Week seeks to mobilize governments, international organizations, civil society organizations and people with lived experience to accelerate the implementation of policies and actions that promote, protect and improve mental health throughout the Region. Mental health remains one of the Region’s major public health challenges, with millions of people continuing to face barriers to accessing quality services and support. “Everyone has the right to the highest attainable standard of health, including mental health.
This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)
Related articles
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!